Medical Research

3D models of uveal melanoma offer hope for improved treatments featured image
Cancer
3D models of uveal melanoma offer hope for improved treatments

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better understand how this disease works and develop treatments for unmet patient needs.

Latest stories

High blood pressure in pregnancy a risk factor for early heart disease featured image
Translational Science
High blood pressure in pregnancy a risk factor for early heart disease
Caitlin Doran
January 7, 2025
Mayo Clinic’s AI tool offers a new way to visualize disease featured image
Individualized Medicine
Mayo Clinic’s AI tool offers a new way to visualize disease
Susan Murphy
January 7, 2025
New study calculates autoimmune disease prevalence in U.S. featured image
AI and Digital Health
New study calculates autoimmune disease prevalence in U.S.
Lynda De Widt
January 6, 2025
Minnesota Partnership awards four collaborative research grants for 2024 featured image
Featured News
Minnesota Partnership awards four collaborative research grants for 2024
Vincent Jacobbi
January 2, 2025
Top cancer research stories of 2024 featured image
Cancer
Top cancer research stories of 2024
Mayo Clinic Staff
December 31, 2024
10 Mayo Clinic research advances in 2024, spanning stem cell therapy in space to growing mini-organs featured image
Research
10 Mayo Clinic research advances in 2024, spanning stem cell therapy in space to growing mini-organs
Mayo Clinic Staff
December 30, 2024
10 pioneering studies from Mayo Clinic’s Center for Individualized Medicine in 2024  featured image
Individualized Medicine
10 pioneering studies from Mayo Clinic’s Center for Individualized Medicine in 2024 
Susan Murphy
December 23, 2024
Addressing the root cause of rare diseases — the promise of antisense oligonucleotides featured image
Individualized Medicine
Addressing the root cause of rare diseases — the promise of antisense oligonucleotides
Marla Broadfoot, Ph.D.
December 19, 2024

Sign up to receive email notifications

Explore more topics

Sign up